Kowa Pharmaceuticals America (Diclofenac Products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 2

Kowa Pharmaceuticals America (Diclofenac Products) General Information

Description

Portfolio of diclofenac products. The portfolio comprises of Cambia a diclofenac potassium for oral consumption used for the treatment of acute migraine headache pain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Assertio Holdings
Corporate Office
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kowa Pharmaceuticals America (Diclofenac Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kowa Pharmaceuticals America (Diclofenac Products)‘s full profile, request access.

Request a free trial

Kowa Pharmaceuticals America (Diclofenac Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kowa Pharmaceuticals America (Diclofenac Products)‘s full profile, request access.

Request a free trial

Kowa Pharmaceuticals America (Diclofenac Products) FAQs

  • Where is Kowa Pharmaceuticals America (Diclofenac Products) headquartered?

    Kowa Pharmaceuticals America (Diclofenac Products) is headquartered in .

  • What industry is Kowa Pharmaceuticals America (Diclofenac Products) in?

    Kowa Pharmaceuticals America (Diclofenac Products)’s primary industry is Buildings and Property.

  • Is Kowa Pharmaceuticals America (Diclofenac Products) a private or public company?

    Kowa Pharmaceuticals America (Diclofenac Products) is a Private company.

  • What is the current valuation of Kowa Pharmaceuticals America (Diclofenac Products)?

    The current valuation of Kowa Pharmaceuticals America (Diclofenac Products) is .

  • What is Kowa Pharmaceuticals America (Diclofenac Products)’s current revenue?

    The current revenue for Kowa Pharmaceuticals America (Diclofenac Products) is .

  • Who are Kowa Pharmaceuticals America (Diclofenac Products)’s investors?

    Kowa Pharmaceuticals America and Nautilus Neurosciences have invested in Kowa Pharmaceuticals America (Diclofenac Products).

  • When was Kowa Pharmaceuticals America (Diclofenac Products) acquired?

    Kowa Pharmaceuticals America (Diclofenac Products) was acquired on 17-Dec-2013.

  • Who acquired Kowa Pharmaceuticals America (Diclofenac Products)?

    Kowa Pharmaceuticals America (Diclofenac Products) was acquired by Assertio Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »